nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimetindene—KCNH2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.0219	0.0219	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Other—S1PR1—multiple sclerosis	0.0198	0.0198	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.0166	0.0166	CbGpPWpGaD
Dimetindene—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.0128	0.0128	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.0116	0.0116	CbGpPWpGaD
Dimetindene—CHRM2—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.0114	0.0114	CbGpPWpGaD
Dimetindene—HRH1—IL-4 Signaling Pathway—IL4—multiple sclerosis	0.0101	0.0101	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Other—CXCR3—multiple sclerosis	0.00967	0.00967	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.00927	0.00927	CbGpPWpGaD
Dimetindene—HRH1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00912	0.00912	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00882	0.00882	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Other—CNR1—multiple sclerosis	0.00869	0.00869	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.00858	0.00858	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00819	0.00819	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00816	0.00816	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—RGS1—multiple sclerosis	0.00789	0.00789	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00749	0.00749	CbGpPWpGaD
Dimetindene—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.00747	0.00747	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00737	0.00737	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00705	0.00705	CbGpPWpGaD
Dimetindene—KCNH2—Neuronal System—BCHE—multiple sclerosis	0.00703	0.00703	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00694	0.00694	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.00684	0.00684	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.00684	0.00684	CbGpPWpGaD
Dimetindene—HRH1—IL-4 Signaling Pathway—TYK2—multiple sclerosis	0.0065	0.0065	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00645	0.00645	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00635	0.00635	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Other—CCR5—multiple sclerosis	0.00606	0.00606	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00604	0.00604	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00594	0.00594	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00571	0.00571	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—S1PR1—multiple sclerosis	0.00562	0.00562	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00552	0.00552	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00552	0.00552	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00544	0.00544	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00544	0.00544	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—GPR65—multiple sclerosis	0.0046	0.0046	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.00456	0.00456	CbGpPWpGaD
Dimetindene—HRH1—IL-4 Signaling Pathway—STAT3—multiple sclerosis	0.00455	0.00455	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00453	0.00453	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—GPR65—multiple sclerosis	0.00453	0.00453	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00442	0.00442	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00441	0.00441	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00436	0.00436	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00435	0.00435	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.00429	0.00429	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00427	0.00427	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCR1—multiple sclerosis	0.00421	0.00421	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CXCL13—multiple sclerosis	0.00421	0.00421	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.0042	0.0042	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00416	0.00416	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCR1—multiple sclerosis	0.00414	0.00414	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CXCL13—multiple sclerosis	0.00414	0.00414	CbGpPWpGaD
Dimetindene—HRH1—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	0.00414	0.00414	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00409	0.00409	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00407	0.00407	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00394	0.00394	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00387	0.00387	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00383	0.00383	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00379	0.00379	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00377	0.00377	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00373	0.00373	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00366	0.00366	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00366	0.00366	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.0036	0.0036	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00356	0.00356	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.0035	0.0035	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00329	0.00329	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00323	0.00323	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00322	0.00322	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00317	0.00317	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00315	0.00315	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00312	0.00312	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCL3—multiple sclerosis	0.003	0.003	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00296	0.00296	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCL3—multiple sclerosis	0.00295	0.00295	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00293	0.00293	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00291	0.00291	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00289	0.00289	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00288	0.00288	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—PTGER4—multiple sclerosis	0.00284	0.00284	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00284	0.00284	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00279	0.00279	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CXCR3—multiple sclerosis	0.00274	0.00274	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00274	0.00274	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	0.00271	0.00271	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—RGS1—multiple sclerosis	0.0027	0.0027	CbGpPWpGaD
Dimetindene—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00268	0.00268	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCR2—multiple sclerosis	0.00267	0.00267	CbGpPWpGaD
Dimetindene—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00263	0.00263	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	0.0026	0.0026	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00256	0.00256	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00255	0.00255	CbGpPWpGaD
Dimetindene—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.00251	0.00251	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00251	0.00251	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	0.0025	0.0025	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	0.00249	0.00249	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	0.00246	0.00246	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	0.00245	0.00245	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00238	0.00238	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00238	0.00238	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	0.00236	0.00236	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	0.00234	0.00234	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00234	0.00234	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	0.00232	0.00232	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00229	0.00229	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.00229	0.00229	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	0.00228	0.00228	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00226	0.00226	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00225	0.00225	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	0.00225	0.00225	CbGpPWpGaD
Dimetindene—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	0.00222	0.00222	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00222	0.00222	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00216	0.00216	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	0.00216	0.00216	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00215	0.00215	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	0.00212	0.00212	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00212	0.00212	CbGpPWpGaD
Dimetindene—KCNH2—Neuronal System—MAPK1—multiple sclerosis	0.00206	0.00206	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	0.00198	0.00198	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	0.00195	0.00195	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	0.00194	0.00194	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	0.00191	0.00191	CbGpPWpGaD
Dimetindene—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.00181	0.00181	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00179	0.00179	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00176	0.00176	CbGpPWpGaD
Dimetindene—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00175	0.00175	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	0.00175	0.00175	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	0.00173	0.00173	CbGpPWpGaD
Dimetindene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00173	0.00173	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	0.00172	0.00172	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	0.0017	0.0017	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GPC5—multiple sclerosis	0.00168	0.00168	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00166	0.00166	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	0.00166	0.00166	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00163	0.00163	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.0016	0.0016	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00157	0.00157	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00155	0.00155	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	0.00154	0.00154	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00153	0.00153	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	0.00151	0.00151	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	0.00151	0.00151	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00148	0.00148	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—RGS1—multiple sclerosis	0.00147	0.00147	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	0.00146	0.00146	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	0.00145	0.00145	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00143	0.00143	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00141	0.00141	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00141	0.00141	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GPR65—multiple sclerosis	0.00139	0.00139	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	0.00139	0.00139	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00139	0.00139	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	0.00137	0.00137	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00137	0.00137	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	0.00137	0.00137	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—POMC—multiple sclerosis	0.00137	0.00137	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	0.00134	0.00134	CbGpPWpGaD
Dimetindene—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.00134	0.00134	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	0.00134	0.00134	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	0.00131	0.00131	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	0.00128	0.00128	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR1—multiple sclerosis	0.00128	0.00128	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	0.00128	0.00128	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00127	0.00127	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	0.00126	0.00126	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	0.00125	0.00125	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	0.00125	0.00125	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00125	0.00125	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	0.00116	0.00116	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	0.00114	0.00114	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	0.0011	0.0011	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	0.00108	0.00108	CbGpPWpGaD
Dimetindene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00105	0.00105	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	0.000995	0.000995	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000987	0.000987	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	0.000979	0.000979	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000973	0.000973	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000971	0.000971	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000957	0.000957	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL3—multiple sclerosis	0.000909	0.000909	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	0.000897	0.000897	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	0.000894	0.000894	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000884	0.000884	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	0.000882	0.000882	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	0.000875	0.000875	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000869	0.000869	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PGR—multiple sclerosis	0.000862	0.000862	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	0.000861	0.000861	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PGR—multiple sclerosis	0.000848	0.000848	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	0.000845	0.000845	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CD28—multiple sclerosis	0.000837	0.000837	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	0.000831	0.000831	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CD28—multiple sclerosis	0.000824	0.000824	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR2—multiple sclerosis	0.000822	0.000822	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	0.000809	0.000809	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	0.000772	0.000772	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	0.000759	0.000759	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CNR1—multiple sclerosis	0.000758	0.000758	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	0.000746	0.000746	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—POMC—multiple sclerosis	0.000701	0.000701	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	0.000689	0.000689	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	0.000686	0.000686	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	0.000683	0.000683	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	0.000675	0.000675	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	0.000672	0.000672	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	0.000623	0.000623	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	0.000613	0.000613	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CD86—multiple sclerosis	0.000597	0.000597	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL5—multiple sclerosis	0.000588	0.000588	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CD86—multiple sclerosis	0.000588	0.000588	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	0.000578	0.000578	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	0.00057	0.00057	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	0.000561	0.000561	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SPP1—multiple sclerosis	0.000544	0.000544	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	0.000536	0.000536	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR5—multiple sclerosis	0.00053	0.00053	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	0.000522	0.000522	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	0.000521	0.000521	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL2—multiple sclerosis	0.000518	0.000518	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	0.000514	0.000514	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	0.00051	0.00051	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—APOE—multiple sclerosis	0.000482	0.000482	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—APOE—multiple sclerosis	0.000474	0.000474	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CD80—multiple sclerosis	0.000436	0.000436	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CD80—multiple sclerosis	0.000429	0.000429	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—POMC—multiple sclerosis	0.000414	0.000414	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—POMC—multiple sclerosis	0.000407	0.000407	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL2—multiple sclerosis	0.000405	0.000405	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	0.000399	0.000399	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000396	0.000396	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	0.00039	0.00039	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TYK2—multiple sclerosis	0.000368	0.000368	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	0.000362	0.000362	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL2—multiple sclerosis	0.000306	0.000306	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL6—multiple sclerosis	0.000304	0.000304	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL2—multiple sclerosis	0.000301	0.000301	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	0.0003	0.0003	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MMP9—multiple sclerosis	0.00029	0.00029	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	0.000285	0.000285	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—STAT3—multiple sclerosis	0.000257	0.000257	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	0.000253	0.000253	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MYC—multiple sclerosis	0.000239	0.000239	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	0.000239	0.000239	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MYC—multiple sclerosis	0.000235	0.000235	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	0.000235	0.000235	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	0.000234	0.000234	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	0.00023	0.00023	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL6—multiple sclerosis	0.00018	0.00018	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL6—multiple sclerosis	0.000177	0.000177	CbGpPWpGaD
